Exometry
PrivateLast Round
Series E
Sep 9, 2020
Est. Valuation
$558M
Total Funding Raised
$179.2M
Company Overview
Exometry operates in Healthcare & Life Sciences and is based in Amsterdam. Its latest recorded funding round was a Series E round in September 2020.
Exometry is a biotechnology company that provides products and software to standardize flow cytometry measurements of extracellular vesicles and other sub-micrometer particles.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Subscription SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Exometry Comparables
Compare Exometry with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Apogee Flow Systems Ltd | 78% | |
| Cellarcus Biosciences | 77% | |
| Neomend | 71% |
For institutional investors. Book with your work email.
Exometry Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Sep 9, 2020 | ||||
| Series D | May 13, 2019 | ||||
| Series C | Jul 12, 2018 | ||||
| Series B | Jun 28, 2017 | ||||
| Series A | Feb 1, 2017 | ||||
VC Round | Nov 5, 2015 |
For institutional investors. Book with your work email.
Exometry Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| StepStone Group | Series E, Series D |
| Highland Capital Partners | Series D, Series C, Series A, Series E, Series B, VC Round |
| Netherlands Organization for Scientific Research | Grant |
| ArrowMark Partners | Series E |
| European Union's Horizon 2020 research and innovation programme (Marie Skłodowska-Curie) | Grant |
| Dell Technologies Capital | Series D, Series E |
| Robert Bosch Venture Capital | Series E |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 9, 2020
$75M round with participation from BMW i Ventures and Robert Bosch Venture Capital.
- May 13, 2019
$50M round led by StepStone Group.
For institutional investors. Book with your work email.
Exometry Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Exometry's valuation, stock price, and market status.
Is Exometry a public or private company?
Exometry is a private company.
What is the current stock price of Exometry?
Exometry is a private company, so its shares have no public market price. Caplight tracks Exometry's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Exometry worth (valuation)?
Exometry's valuation is estimated at $558.0M based on funding round data.
Can I buy Exometry stock?
Exometry shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Exometry's last funding round?
Exometry's most recent funding round was Series E on September 9, 2020.
Who are the main investors in Exometry?
Key investors in Exometry include StepStone Group, Highland Capital Partners, Netherlands Organization for Scientific Research, European Metrology Programme for Innovation and Research, Foundry Group.
Will Exometry IPO soon?
No public IPO plans have been announced for Exometry.
How can I track Exometry secondary market activity?
Caplight tracks bids, offers, and trades in Exometry's shares on secondary markets.